Brind.

Legend Biotech and Johnson & Johnson announced their collaboration on CARVYKTI, while Legend Biotech also utilized LinkedIn for professional presence.

5 reports, 4 independent Updated Sep 3
Gone quiet Reached 2 outlets in its first 24 hours
Reports
5
Developments
3
Repetition
40%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 4 independent outlets

Legend Biotech and Johnson & Johnson announced their collaboration on CARVYKTI, while Legend Biotech also utilized LinkedIn for professional presence.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Legend Biotech and Johnson & Johnson are manufacturing their drug Carvykti at a facility located in Raritan, New Jersey.1 source
  2. Legend Biotech develops CARVYKTI with Johnson & Johnson and uses LinkedIn for professional presence.1 source
  3. The collaboration between Legend Biotech and J&J for Carvykti is generating optimism.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • biopharmadive.com
  • fool.com
  • GlobeNewswireLegend Biotech to Host Investor Conference Call on Second Quarter 2025 Results SOMERSET, N.J., July 28, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global l
  • ZacksLegend Biotech (LEGN) Surges 6.0%: Is This an Indication of Further Gains? Legend Biotech Corporation Sponsored ADR (LEGN) shares soared 6% in the last trading session to close at $42.13. The move wa
1 more outlet ran the same wire story